Sign In

Kay Chang

Professor at Stanford University School of Medicine

Professional Background

Dr. Kay Chang is a prominent figure within the field of Pediatric Otology, bringing a wealth of knowledge and expertise to his clinical practice at Lucile Packard Children's Hospital. His career is driven by his unwavering commitment to improving hearing health in children, particularly focusing on congenital hearing loss and its associated anomalies. As a physician, Dr. Chang's specialized clinical interests encompass a range of complex issues, including congenital ear anomalies, microtia and atresia reconstruction, and the nuanced realm of pediatric cochlear implantation.

In addition to his clinical role, Dr. Chang is actively engaged in groundbreaking research that addresses critical aspects of hearing loss in children. His studies encompass a wide variety of topics, such as neonatal hearing screening, the genetic foundations of hearing loss, otoacoustic emissions, and the auditory physiology of young patients. His research is particularly notable for its emphasis on understanding and preventing ototoxicity, especially in the context of chemotherapy. Dr. Chang’s involvement in several human clinical trials aimed at preventing cisplatin ototoxicity underscores his dedication to creating a future where fewer children are impacted by chemotherapy-related hearing loss. A valuable contribution to this area is his presentation of the Chang Ototoxicity Scale, published in the Journal of Clinical Oncology, showcasing his innovative approach to evaluating and addressing this critical issue.

Currently, Dr. Chang's research interests are broadening into the exploration of congenital inner ear anomalies through sophisticated radiologic evaluations. He is also delving into the genetic landscape by analyzing how Connexin-based mutations can significantly influence management strategies for infants struggling with congenital hearing loss. His research not only seeks to enhance clinical practices but also aims to inspire new therapeutic strategies for young patients who face hearing challenges.

Education and Achievements

Dr. Chang's educational journey is marked by excellence and recognition. He began his academic career at Brown University, where he completed his Bachelor of Arts in Cognitive Science, graduating magna cum laude and earning the distinction of Phi Beta Kappa. His exceptional performance continued as he progressed to complete his MD degree at The Warren Alpert Medical School of Brown University, earning prestigious accolades including the Henry Randall Prize and the Sigma Xi Award.

Following his medical education, Dr. Chang undertook an Otolaryngology residency at the University of Washington in Seattle, which provided him with a solid foundation in the intricacies of ear, nose, and throat health. He further refined his skills in a fellowship program focusing on Pediatric Otolaryngology at the renowned Children’s Hospital of Pittsburgh.

After establishing a robust clinical and academic career, Dr. Chang joined the esteemed faculty at Stanford University in the year 2000. During his time at Stanford, he has held several notable positions, including Professor and Associate Professor at the Stanford University School of Medicine, building a legacy that inspires both medical students and peers alike.

Achievements

Throughout his illustrious career, Dr. Chang has made significant advancements in the field of Pediatric Otology and auditory research. His contributions are not merely confined to clinical practice; they extend into academic research and education. By participating in and leading numerous clinical trials, he has successfully contributed to the development of solutions aimed at preventing hearing loss in children caused by toxicities from treatments like cisplatin.

His scholarly contributions, particularly regarding topics such as the diagnosis and management of congenital hearing loss, reflect his deep commitment to improving pediatric healthcare outcomes. Through his research publications, including the well-regarded Chang Ototoxicity Scale, Dr. Chang has positioned himself as a leader in his field, invoking both curiosity and respect from colleagues and peers.

Moreover, his involvement in organizations related to pediatric health and otology enhances his influence and connection with like-minded professionals dedicated to advancing the quality of life for young individuals with hearing impairments. Dr. Chang's dedication to his patients and his relentless pursuit of knowledge and clinical excellence exemplify his distinguished standing as a leader in Pediatric Otology.

In summary, Dr. Kay Chang embodies the epitome of a dedicated pediatric otolaryngologist. His robust background in clinical practice, extensive research interests, and profound educational achievements solidify his status as a valuable asset within the medical community. Dr. Chang's work not only impacts immediate patient care but also paves the way for future advancements in the field, ensuring that the next generation of pediatric patients receives cutting-edge care in hearing health. His contributions speak volumes about his expertise and the passion he has for making a difference in the lives of children with hearing challenges.

Related Questions

What inspired Dr. Kay Chang to specialize in Pediatric Otology?
How has Dr. Kay Chang contributed to advancing the understanding of congenital hearing loss?
What are the most significant impacts of Dr. Kay Chang's research on pediatric ototoxicity?
How does Dr. Kay Chang approach the complex surgeries associated with microtia reconstruction?
In what ways has Dr. Kay Chang's education shaped his clinical practice and research philosophy?
Kay Chang
Add to my network

Location

Stanford, California, United States